Concepedia

C M Svahn

CM

Statistics

Publications

12

Citations

1.7K

H-Index

12

Active since

1989

Affiliations

Technion – Israel Institute of Technology(Current)

Institute of Organic Chemistry

Washington University in St. Louis

C M Svahn is an author at Technion – Israel Institute of Technology specializing in life sciences, biochemistry, and heparin-protein interactions.

Publications per year

1989–1997

12

Publications

12

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.

David M. Ornitz, Avner Yayon, John G. Flanagan et al. · Molecular and Cellular Biology · 1992 · 625 citations · Full text

, , +16

FGF Binding and FGF Receptor Activation by Synthetic Heparan-Derived Di- and Trisaccharides

David M. Ornitz, Andrew B. Herr, Marianne Nilsson et al. · Science · 1995 · 273 citations

, , +17

Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.

David Aviezer, Ehud Levy, Michal Safran et al. · Journal of Biological Chemistry · 1994 · 254 citations · Full text

, , +17

Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin.

Shay Söker, C M Svahn, Gera Neufeld · Journal of Biological Chemistry · 1993 · 119 citations · Full text

, , +11

Variations in the Size and Sulfation of Heparin Modulate the Effect of Heparin on the Binding of VEGF165 to Its Receptors

Shay Söker, Dan Goldstaub, C M Svahn et al. · Biochemical and Biophysical Research Communications · 1994 · 110 citations

, , +11

1–5 of 12